ceftazidime-monobactam and Femoral-Fractures

ceftazidime-monobactam has been researched along with Femoral-Fractures* in 1 studies

Other Studies

1 other study(ies) available for ceftazidime-monobactam and Femoral-Fractures

Article	Year
[Pseudomonas stutzeri osteitis: A case study]. Medecine et maladies infectieuses, 2006, Volume: 36, Issue:10 We report a case of osteitis in a 46-year-old patient, caused by Pseudomonas stutzeri following an open fracture of the left femur. The patient was treated with 1g ceftazidime every 8 hours for two weeks combined with 160 mg/day of amikacin for 10 days. A second-line ofloxacin oral treatment at 400 mg/day was then given during 4 weeks. Surgical treatment consisted in debridement of the fracture region. Sterilization of the fracture region led to an osteosynthesis by blade plate and bone graft. The result was favorable. Topics: Anti-Bacterial Agents; Ceftazidime; Drug Administration Schedule; Femoral Fractures; Humans; Male; Middle Aged; Monobactams; Pseudomonas Infections; Pseudomonas stutzeri; Treatment Outcome	2006

Article

Year

[Pseudomonas stutzeri osteitis: A case study].

Medecine et maladies infectieuses, 2006, Volume: 36, Issue:10

We report a case of osteitis in a 46-year-old patient, caused by Pseudomonas stutzeri following an open fracture of the left femur. The patient was treated with 1g ceftazidime every 8 hours for two weeks combined with 160 mg/day of amikacin for 10 days. A second-line ofloxacin oral treatment at 400 mg/day was then given during 4 weeks. Surgical treatment consisted in debridement of the fracture region. Sterilization of the fracture region led to an osteosynthesis by blade plate and bone graft. The result was favorable.

Topics: Anti-Bacterial Agents; Ceftazidime; Drug Administration Schedule; Femoral Fractures; Humans; Male; Middle Aged; Monobactams; Pseudomonas Infections; Pseudomonas stutzeri; Treatment Outcome

2006